According to The Wall Street Journal: Startup Red Queen Bio, supported by OpenAI, will begin human trials of its antibody drug next year.
2026-09-28 12:03:33
According to CoinMeta, as reported by The Wall Street Journal, the startup Red Queen Bio, which is supported by OpenAI, will begin human trials of antibody drugs next year.
Source:The Wall Street Journal
This content is for market information only and does not constitute investment advice.
Follow HKWDB official accounts to stay updated

Hot Articles
Refresh

What is Solidigm? Is Its $150B IPO Valuation a Bubble?
2h ago

Is PAXG Stable? Is Gold-Backed Better Than Stablecoins?
09-24 18:04

ETH Rebounds to $2,800: Can It Hold $3,200 by Month-End?
09-23 11:07

What is Bybit Exchange? Is Bybit Safe with EU Dual Licenses?
09-21 18:42

Bitcoin 5-Year Outlook: $75.5K Miner Cost, Crash or Floor?
09-20 19:23



